Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Merck raises stakes in lung cancer as rivals close in

      Merck raises stakes in lung cancer as rivals close in

      Ruby Khatun Khatun14 Dec 2017 10:01 AM IST
      LOS ANGELES: Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could...
      Orchid Pharma gets USFDA nod for schizophrenia drug

      Orchid Pharma gets USFDA nod for schizophrenia drug

      Ruby Khatun Khatun14 Dec 2017 10:00 AM IST
      New Delhi: Orchid Pharma said it has received approval from the US health regulator for Aripiprazole Orally-Disintegrating tablets, used in the...
      GSKs new pharma head on lookout for cancer deals to boost pipeline

      GSK's new pharma head on lookout for cancer deals to boost pipeline

      Ruby Khatun Khatun14 Dec 2017 9:45 AM IST
      LONDON: GlaxoSmithKline (GSK) will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its...
      Sanofi investors hungry for drug progress and deal news

      Sanofi investors hungry for drug progress and deal news

      Ruby Khatun Khatun14 Dec 2017 9:30 AM IST
      PARIS: Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its...
      Nicotine gums should not be sold OTC-health dept tells DGCI

      Nicotine gums should not be sold OTC-health dept tells DGCI

      Ruby Khatun Khatun13 Dec 2017 4:25 PM IST
      New Delhi: The Delhi government's health department has written to the Drug Controller General of India (DGCI) for stopping the over-the-counter sale...
      Sanofi gets FDA approval for its Mealtime Insulin Admelog

      Sanofi gets FDA approval for its Mealtime Insulin Admelog

      Ruby Khatun Khatun13 Dec 2017 1:45 PM IST
      Paris, France: The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog®, the first follow-on insulin lispro to help people living...
      Alembic Pharma gets USFDA approval for bladder drug

      Alembic Pharma gets USFDA approval for bladder drug

      Ruby Khatun Khatun13 Dec 2017 11:00 AM IST
      New Delhi: Alembic Pharmaceuticals has received US health regulator's nod for a drug used to treat overactive bladder with symptoms of urinary...
      Apollo Pharmacy misappropriation case: CBI carries out searches in BEL hospital

      Apollo Pharmacy misappropriation case: CBI carries out searches in BEL hospital

      Ruby Khatun Khatun13 Dec 2017 10:40 AM IST
      New Delhi: The CBI has carried out searches at three locations in Bengaluru in connection with alleged misappropriation of over Rs 44 lakh by an...
      Apollo Munich eyes 30 percent growth in FY18 premium collection

      Apollo Munich eyes 30 percent growth in FY18 premium collection

      Ruby Khatun Khatun13 Dec 2017 10:15 AM IST
      HYDERABAD: Apollo Munich Health Insurance said it expects 30 percent growth in the premium collection to Rs 1,700 crore by the end of the current...
      Amgens Kyprolis improves overall survival in blood cancer patients

      Amgen's Kyprolis improves overall survival in blood cancer patients

      Ruby Khatun Khatun13 Dec 2017 10:00 AM IST
      Amgen Inc said on Monday a final analysis of late-stage trial data showed that its Kyprolis combined with two other drugs helped blood cancer patients...
      Roche: Tecentriq cocktail slows kidney cancer progression

      Roche: Tecentriq cocktail slows kidney cancer progression

      Ruby Khatun Khatun13 Dec 2017 9:45 AM IST
      ZURICH: Combining Roche’s Tecentriq immunotherapy with its older drug Avastin for the initial treatment of advanced kidney cancer reduced the risk of...
      Philippine senator criticizes reckless disregard in dengue vaccine program

      Philippine senator criticizes reckless disregard in dengue vaccine program

      Ruby Khatun Khatun13 Dec 2017 9:30 AM IST
      MANILA: Philippine public officials showed “reckless disregard of processes” in carrying out a program to immunize hundreds of thousands of children,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok